Clinical Trial Update: Study of a Polygenic Risk Score to Predict the Risk of Pancreatic Ductal Adenocarcinoma [NA]

View source ↗

Summary

This clinical trial entry describes a study evaluating a polygenic risk score to predict the risk of pancreatic ductal adenocarcinoma, with the study currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: Catholic University of the Sacred Heart | Conditions: Pancreatic Ductal Adenocarcinoma (mPDAC) | NA | Status: NOT_YET_RECRUITING